In this study, we found that patients with sepsis have microcirculation changes associated with hypoalbuminemia. These children have endothelial glycocalyx degradation more often, a greater density of small 4–6 µm capillaries recruited, and increased redistribution of blood flow toward the microcirculation. In addition, we found that children with hypoalbuminemia have more elevated biomarkers of increased endothelial permeability, greater inflammatory response and require mechanical ventilation more often. The group who received albumin replacement for hypoalbuminemia showed recovery of the microcirculation and glycocalyx variables and had a shorter PICU stay and lower mortality.
The microcirculation is the terminal effector site of the cardiovascular circulatory system, where the supply of oxygen to the tissues and elimination of metabolic waste are coupled and controlled. In the capillaries, the passage of fluid from the intravascular to the interstitial space is controlled by hydrostatic pressures, capillary oncotic pressure and sub-glycocalyx pressure [5, 6, 18]. In the microcirculation, albumin, besides regulating the flow of liquid between the different spaces, can have immunomodulating effects in patients with sepsis. Studies in animal models have found that normal albumin levels favor sphingosine-1-phosphate transport in the red blood cells and platelets [22, 23]. This sphingolipid has a high capacity for eliminating the matrix metalloproteinases responsible for degrading the glycocalyx and magnifying the inflammatory response in patients with sepsis [24–26]. In our study, we found greater glycocalyx degradation in children with sepsis and hypoalbuminemia, which was associated with a greater inflammatory response and elevated cell death biomarkers.
In sepsis, hypoalbuminemia has been associated with worse outcomes, including an up to 23 times greater risk of death. That is, for each 2.5 gm/dl below its normal value, the odds of death increase 24–56% [13–17]. Recently, with artificial intelligence techniques and machine learning-based models which perform non-linear analyses, low albumin has been found to be one of the most useful serum biomarkers for predicting survival in critically and chronically ill patients [17]. Albumin, besides being the most important protein for maintaining the colloid-osmotic pressure of plasma, is responsible for carrying many endogenous molecules (anti-inflammatory and immunomodulatory molecules) and exogenous molecules (like antibiotics) [14, 15]. It has important anti-inflammatory and antioxidant properties [20, 21]. The group with the lowest albumin in our study, in addition to being associated with microcirculation disorders, had a greater inflammatory response and worse outcomes, like a greater need for mechanical ventilation. This could be explained by increased recruitment of small pulmonary capillaries in children with hypoalbuminemia associated with increased vascular permeability due to sepsis (we found elevated angiopoietin-2), which would favor more capillary leakage toward the alveolar units, a higher risk of pulmonary edema, and therefore, a longer duration of mechanical ventilation support.
In an animal model of hemorrhagic shock, 5% albumin resuscitation, which is similar to the body’s protein content, restores the glycocalyx when compared with crystalloids [27]. These effects may be mediated by greater sphingosine-1-phosphate release from the red blood cells and the platelets. In a recent study, Fernández-Sarmiento et al. [28] found that, in children with sepsis, saline solution was associated with greater endothelial glycocalyx degradation, and that patients with hypoalbuminemia and albumin infusion replacement had a lower risk of microcirculation disorders (aOR 0.56 95% CI 0.31–0.98). Serum albumin replacement may have beneficial effects on the respiratory, cardiovascular, and neurological systems as well as the circulatory status [16].
In this regard, the Saline versus Albumin Fluid Evaluation (SAFE) study compared the impact on mortality in critically ill adults of receiving 0.9% normal saline solution versus 4% albumin as replacement fluid during fluid resuscitation [29]. No differences were found in terms of mortality, but patients who received fluid resuscitation with albumin required a 30% lower volume of fluids during resuscitation. Later, the ALBIOS study evaluated the effect of simultaneous administration of 20% albumin and crystalloids to maintain blood albumin levels equal to or greater than 3.0 gm/dL [30]. Patients who had better albumin levels had their vasopressors or inotropes discontinued sooner, less positive balances, and greater macrocirculation stability. Recently, Raghunathan K et al. [31] found that patients with sepsis and acute kidney injury who received albumin infusions had shorter hospital stays than those who did not receive replacement (hazard ratio, 1.83; 95% CI, 1.56–2.15; p < 0.001). Albumin replacement and maintaining levels greater than 3.0 gm/dL in critically ill patients has been considered a cost-effective approach, showing an almost 20% reduction in care costs for patients with septic shock [32]. In our study, we found that patients who received albumin replacement experienced endothelial glycocalyx degradation recovery, and this group had a shorter hospital stay and lower mortality. Our hypothesis is that maintaining albumin levels above 3 gm/dL stabilized the endothelial glycocalyx and decreased its degradation, and therefore fewer glycocalyx degradation products were released to potentially magnify inflammation and behave as damage-associated molecular patterns (DAMPs) [33–35].
There is increasing evidence of the association between hypoalbuminemia and clinical outcomes in critically ill patients. Leite H et al. found that a 1.0 gm/dL increase in serum albumin on admission was related to a 73% reduction in the risk of death (HR 0.27; 95% CI 0.14–0.51; p < 0.01) [36]. A 1 gm/dL increase in serum albumin was independently associated with a 33% greater probability of early discharge from the PICU (HR 1.33; 95% CI 1.07–1.64; p = 0.008) and an increase in ventilator-free-days (OR 1.86; 95% CI 0.56–3.16; p = 0.005). In our study, we found that patients in whom hypoalbuminemia was corrected had less positive fluid balances and a shorter PICU stay. We should carry out clinical studies evaluating the role of albumin infusions in outcomes like endothelial dysfunction, glycocalyx degradation and possible patient subgroups who could benefit more than others, decreasing the time on mechanical ventilation or mortality.
Limitations
We consider that our study has several limitations. First, it was performed at a single reference center for highly complex patients. This could lead to the included patients being much more ill. However, the severity and organ dysfunction scales were similar in the groups with and without hypoalbuminemia, despite changes found in the microcirculation. In addition, we did not differentially analyze patients with malnutrition. This group could have underlying conditions associated with chronic microcirculation changes and worse outcomes. We tried to control for this variable in the multivariate analysis. However, we are not aware of studies evaluating how nutritional status affects end-tissue perfusion and microcirculation. Finally, due to the available budget, we did not measure cytokines nor conduct long-term follow up of the acid-base status or chloride levels in our patients to determine if there was a relationship between albumin levels, microcirculation changes, and glycocalyx degradation which could be explained by an abnormal inflammatory response or acid-base balance or hyperchloremia [37, 38].